Pfizer Ends Patent War Over Generic Neurontin
Pfizer Inc. on Tuesday dropped the remaining defendants from a long-running patent infringement suit in New Jersey over generic versions of the epilepsy drug Neurontin....To view the full article, register now.
Already a subscriber? Click here to view full article